Organic Chemistry TRIZ Cases

Modifying heterocyclic ring structures creates antiviral agents that overcome viral resistance while maintaining effectiveness.

Novel heteroaryl substituted spiropiperidinyl compounds inhibit leukotriene C4 synthase activity.

A negative resist composition with a carboxylic acid salt quencher achieves high resolution patterns.

Tetrahydropyrazolopyrimidine compounds inhibit Toll-like receptors 7 and 8, reducing disease severity in systemic lupus erythematosus models.

Replacing carboxylic acids with cycloalkyl-dione derivatives improves membrane permeability and reduces toxicity while maintaining target binding affinity.

Aromatic linker bonds between host compounds and red phosphorescent dopants resolve insufficient energy transfer limitations in conventional OLED structures.

Composite organic thin films using nitrogen heterocycles improve electron injection and transport, extending the lifespan of organic EL devices.

A triarylamine charge transporting material with a biphenyl skeleton reduces driving voltage in organic electroluminescent elements.

Modifying molecular parameters of pyrrolo[1,2-b]pyridazine compounds improves blood-brain barrier penetration while reducing cholinergic side effects.

Multi-cyclic compounds in the polymer main chain increase molecular mobility, accelerating photoreaction rates while maintaining high thermal stability.

Synthesizing difluorothienothiophene monomers via oxidation and bromination to create conjugated polymers with optimized energy levels.

Optically active amino acids react with isothiocyanates to form thiohydantoins, which undergo selective reduction to yield chiral imidazole 2-thiones.

Quinone compound prevents polymer dopant de-doping at high temperatures, suppressing equivalent series resistance increase.

Fused ring amine compounds resolve the trade-off between treatment efficiency and toxic side effects in depression therapy.

Grafting alkyl groups onto hollow carbon nanocapsules solves dispersion issues in organic phases, increasing load bearing capacity by 56%.

Composite amine hardener lowers epoxy viscosity without non-incorporatable thinners, preventing CO2-induced blushing in humid conditions.

Pyrimidine carboxamide derivatives selectively inhibit COX-2 while sparing COX-1, reducing gastrointestinal toxicity in arthritis treatment.

Cleavable masking group shifts fluorescence emission wavelength upon amine oxidase activation, resolving low quantum yield and poor diagnostic efficacy.

Fed-batch fermentation combines linoleic and oleic acid to boost lipstatin yield coefficient by 100% while maintaining operational simplicity.

Indolinyl compounds inhibit viral helicase-primase enzymes, reducing herpesvirus shedding and transmission risks.

Photo-polymerizable organic film composition replaces mechanical dispensing to resolve alignment defects and achieve high display resolution.

An organic compound with a triphenylene skeleton and nitrogen-containing chalcogen heterocyclic skeleton improves energy transfer.

Constrained alicyclic rings in the polyimide precursor lower thermal expansion to 100 ppm/K, preventing warpage during fine circuit formation.

Planar indolizine donors overcome energy barriers from electron-deficient motifs, enabling efficient charge transfer in dye-sensitized solar cells.

A 1,3,4-oxadiazolone compound inhibits PIM kinases through specific molecular structure design.

A phenolsulfonic acid aryl ester compound acts as a developing agent in thermal recording materials.

Synthesizing a donor-acceptor polymer using thiophene and isopyrazole units enables stable n-doping through controlled electrochemical cycling.

Host materials with specific T1 and Tn energy levels increase triplet-triplet annihilation probability, raising delayed fluorescence proportion above 5 percent.

Formula I compounds activate the Nrf2 pathway, upregulating protective proteins to treat oxidative stress diseases like neurodegeneration.

Replacing unavailable methyl dichlorobenzoate with brominated precursors resolves low selectivity and yield issues in industrial production.

Combining MDM2 inhibitors with anti-cancer agents targets multiple signaling pathways to reduce toxic side effects while enhancing anti-cancer efficacy.

Benzimidazolodiazocines resolve the trade-off between device efficiency and material complexity by optimizing triplet energy levels.

Bicyclic pyrazolyl amines inhibit cyclin-dependent kinase 2 to overcome treatment resistance in deregulated cancers.

Formula I electroactive materials enhance device performance by optimizing charge transport and luminescence efficiency through tunable molecular substituents.

Fluorinated compounds block alpha v integrins, reducing fibrotic tissue formation and angiogenesis while improving safety profiles.

Using a bicarbazyl derivative as the electrode mediator stabilizes cation radicals to achieve higher discharge potential and longer cycle life.

Furan 2,5-di-ester plasticizers resolve volatility and stability issues during hot melt processing of hydrophilic polymeric compositions.

Anthryl and phenanthrolinyl groups in an organic compound enhance electron mobility and glass transition temperature.

A polyimide-amide copolymer forms via carbonate cyclization to yield high light transmittance and thermal stability.

Amide compounds with defined heterocyclic cores selectively target ROCK enzymes, reducing off-target side effects while maintaining potent inhibition.

Enteric coatings target metformin release to the intestine, reducing plasma concentrations and lactic acidosis risk in renal patients.

A fluorine-containing ether compound forms a thin lubricating layer on magnetic recording media to reduce magnetic head floating height.

Novel aldehyde dehydrogenase inhibitor compounds target the ALDH1A3 enzyme to enable targeted therapeutic interventions.

Difluorothiophene-based compounds boost electron mobility in n-type semiconductors, overcoming the low conductivity limits of fullerene materials.

Phenol derivative with polymerizable functional groups lowers viscosity while maintaining strong substrate adhesion in cationic curable compositions.

Mixing high and moderate basicity side chains on naphthalene diimides balances G-quadruplex binding affinity against cellular uptake limitations.

Substituting chloroacetic acid with bromoacetic acid in the reaction system improves production efficiency and yield for pharmaceutical intermediates.